• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
    • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Exploring Vacuum Technology in Pharmaceutical Processing
    Sterile Manufacturing Technology Trends
    Optimizing Drug Solubility
    Welcome to the 28th CPhI Worldwide!
    CMOs/CDMOs: Challenges and Opportunities
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Financial Report: Johnson & Johnson
    Financial Results Roche YTD17
    Novartis to Close Sandoz Facility
    CPhI Report Evaluates Innovative Mfg. Processes
    Servier CDMO Expands Chromatography Platform in Normandy
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Servier CDMO Expands Chromatography Platform in Normandy
    NJ Innovation Institute, Rutgers form Continuous Mfg. Institute
    CordenPharma Invests in Small Molecule API Development Capacity
    Batavia Biosciences Expands GMP Facilities
    FDA Approves Samsung Biologics’ Second Plant
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Vetter Expands Secondary Packaging Capacities
    Almac Launches Pod Services
    Bormioli Rocco Pharma Strengthens Service to NA Market
    Sterile Manufacturing Future Trends and Challenges
    Tubilux Selects TraceLink to Achieve EU FMD Compliance
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Quotient Clinical, Nuformix Ink Cocrystal Formulation Pact
    Boehringer, TARGET Pharma in Strategic NASH Pact
    Plasticell, GSK Ink iPSCs Screening Pact
    Aeglea BioTherapeutics, Merck Enter Clinical Collaboration
    Batavia Biosciences Expands GMP Facilities
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    FDA Approves Samsung Biologics’ Second Plant
    PBOA Hosts First Members Meeting & Conference
    ANDA Refuse-to-Receive Pitfalls and How to Avoid Them
    Contracting & Outsourcing Session Highlights and Key Takeaways
    What are GMPs?
    Companies
    Categories
    Corporate Capabilities
    Contract Service Directory Companies
    Federal Equipment Company
    Midwest Compliance Laboratories
    Nitto Avecia Pharma Services
    Capsugel
    Juniper Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Federal Equipment Company
    Webinars
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Register Now
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    MannKind Ends Afrezza License with Sanofi

    Will transition development and commercialization to MannKind

    Related Breaking News
    • Afrezza Gets Panel Date
    • Sanofi, MannKind Enter Global Afrezza Pact
    • MannKind Earns $50M Sanofi Milestone
    • 3 Sanofi-Aventis
    • 3 Sanofi
    01.05.16
    MannKind Corp. has terminated its license and collaboration agreement with Sanofi-aventis U.S. for the development and commercialization of Afrezza (insulin human) Inhalation Powder. The companies will transition the development and commercialization of Afrezza from Sanofi to MannKind within 180 days.
     
    MannKind is reviewing its strategic options for Afrezza as a result of the termination of the Sanofi collaboration.
    Related Searches
    • Drug Development
    • license
    • collaboration
    • Development
    Suggested For You
    Crown Bioscience Enters Antibody Collaboration Crown Bioscience Enters Antibody Collaboration
    Regeneron, SillaJen in Clinical and Supply Pact Regeneron, SillaJen in Clinical and Supply Pact
    Domain, Pfizer in bioSensAll Alliance Domain, Pfizer in bioSensAll Alliance
    AMO Pharma, Ranedis Pharmaceuticals Form Pact AMO Pharma, Ranedis Pharmaceuticals Form Pact
    Alcami Expands Analytical Capabilities Alcami Expands Analytical Capabilities
    Bayer Strengthens U.S. Animal Health Portfolio Bayer Strengthens U.S. Animal Health Portfolio
    Two Strikes, Two Outs, or Time Out? Inhalation for Systemic Effect Two Strikes, Two Outs, or Time Out? Inhalation for Systemic Effect
    Financial Report: Evotec Financial Report: Evotec
    Top 25 Pharma and Biopharma Report Top 25 Pharma and Biopharma Report
    3 Sanofi 3 Sanofi
    3 Sanofi-Aventis 3 Sanofi-Aventis
    MannKind Earns $50M Sanofi Milestone MannKind Earns $50M Sanofi Milestone
    Sanofi, MannKind Enter Global Afrezza Pact Sanofi, MannKind Enter Global Afrezza Pact
    Afrezza Gets Panel Date Afrezza Gets Panel Date

    Related Breaking News

    • Collaborations & Alliances
      Aeglea BioTherapeutics, Merck Enter Clinical Collaboration

      Aeglea BioTherapeutics, Merck Enter Clinical Collaboration

      To evaluate the combination of Aeglea’s AEB1102 with Merck’s KEYTRUDA for the treatment of Small Cell Lung Cancer
      10.16.17
    • cGMP Manufacture | Industry News
      Batavia Biosciences Expands GMP Facilities

      Batavia Biosciences Expands GMP Facilities

      Enhances capabilities at R&D facility in Medford, MA and expands GMP clean room facilities in Leiden
      10.16.17
    • Breaking News | Collaborations & Alliances | Industry News
      SGS and Bavarian Nordic Form Vaccine Collaboration

      SGS and Bavarian Nordic Form Vaccine Collaboration

      Will develop a novel and differentiated challenge model for respiratory syncytial virus
      10.16.17
    • Collaborations & Alliances
      AbbVie, Turnstone Biologics Enter Immunotherapy Agreement

      AbbVie, Turnstone Biologics Enter Immunotherapy Agreement

      Gains option to license three of Turnstone's next-gen oncolytic viral immunotherapies
      10.11.17
    • cGMP Manufacture | Industry News
      MilliporeSigma Opens Burlington Life Science Center

      MilliporeSigma Opens Burlington Life Science Center

      280,000-sq.-ft. facility will serve as a regional hub for global customers
      10.11.17
    • Collaborations & Alliances
      SELLAS, Merck Enter Clinical Trial Collaboration and Supply Pact

      SELLAS, Merck Enter Clinical Trial Collaboration and Supply Pact

      Combination trial with Galinpepimut-S and KEYTRUDA to be studied across in five cancers
      10.03.17
    • Collaborations & Alliances
      Thermalin, Sanofi to Develop Next-Gen Insulin Therapies

      Thermalin, Sanofi to Develop Next-Gen Insulin Therapies

      Aims to discover and develop novel, engineered insulin analogues
      09.29.17
    • cGMP Manufacture | Industry News | Scale-up/ Technology Transfer
      Heat Biologics, KBI Biopharma Enter Development/Mfg. Pact

      Heat Biologics, KBI Biopharma Enter Development/Mfg. Pact

      KBI Biopharma to provide development and manufacturing services for cancer immunotherapies
      09.28.17
    • Industry News
      Achaogen Awarded $18M BARDA Contract

      Achaogen Awarded $18M BARDA Contract

      To support clinical development of antibacterial candidate for ESBL infections
      09.28.17
    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      Selexis and OSE Immunotherapeutics Expand Strategic Alliance

      Selexis and OSE Immunotherapeutics Expand Strategic Alliance

      To further advance cancer immunotherapy programs
      09.27.17
    • Clinical Trial Materials | Cytotoxics and High Potency Manufacturing | Facilities | Process Development | Scale-up/ Technology Transfer
      ADC Bio Invests $11M in Bioconjugation Facility

      ADC Bio Invests $11M in Bioconjugation Facility

      Will provide capabilities and R&D technical services from process development through to manufacturing
      09.25.17
    • Industry News
      LabCentral, Pfizer to Open Next-Stage Facility

      LabCentral, Pfizer to Open Next-Stage Facility

      New, 33,000-sq.-ft. lab will house as many as six early- to mid-stage companies
      09.21.17
    • cGMP Manufacture | Fill/Finish | Industry News
      Catalent to Acquire Cook Pharmica for $950M

      Catalent to Acquire Cook Pharmica for $950M

      Expands biologics development and analytical services, manufacturing, and finished product supply
      09.19.17
    • Bio News | Breaking News | Clinical Trial Materials | Industry News
      Emergent BioSolutions Wins $63M BARDA Contract

      Emergent BioSolutions Wins $63M BARDA Contract

      Will develop treatment for cyanide exposure together with Southwest Research Institute
      09.18.17
    • Breaking News | Clinical Trial Materials | Industry News
      Ardena Launches following Pharmavize and Crystallics Merger

      Ardena Launches following Pharmavize and Crystallics Merger

      Will offer solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing
      09.11.17
    Trending
    • Philadelphia CRO Acquired By Investment Fund
    • Amgen Launches New Commercial Hong Kong Ops
    • CPhI Report Evaluates Innovative Mfg. Processes
    • Regeneron, Teva Ink Global NGF Antibody Alliance
    • ABL Acquisition Extends Ardena’s Early-phase Offering
    Breaking News
    • Financial Report: Johnson & Johnson
    • Financial Results Roche YTD17
    • Novartis to Close Sandoz Facility
    • CPhI Report Evaluates Innovative Mfg. Processes
    • Servier CDMO Expands Chromatography Platform in Normandy
    View Breaking News >
    CURRENT ISSUE

    October 2017
    • Exploring Vacuum Technology in Pharmaceutical Processing
    • Sterile Manufacturing Technology Trends
    • Optimizing Drug Solubility
    • Welcome to the 28th CPhI Worldwide!
    • CMOs/CDMOs: Challenges and Opportunities
    • Maximizing Strategic External Service Provider Relationships In-House
    • The Future of Inhaled Medications and Inhalation Technology
    • CEO Spotlight: Samsung Biologics
    • CEO Spotlight: Catalent
    • The Challenges of Drug Development
      • View More >

    Copyright © 2017 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.